Akso Health Group Statistics

Total Valuation

FRA:8HX has a market cap or net worth of EUR 980.23 million. The enterprise value is 972.54 million.

Market Cap	980.23M
Enterprise Value	972.54M

Important Dates

The next estimated earnings date is Monday, March 16, 2026.

Earnings Date	Mar 16, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+204.20%
Shares Change (QoQ)	+74.72%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	856.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	77.49
PB Ratio	5.80
P/TBV Ratio	6.37
P/FCF Ratio	n/a
P/OCF Ratio	158.49
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.41
EV / Sales	77.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.77

Financial Position

The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.01.

Current Ratio	1.53
Quick Ratio	1.19
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -68.29% and return on invested capital (ROIC) is -2.55%.

Return on Equity (ROE)	-68.29%
Return on Assets (ROA)	-1.42%
Return on Invested Capital (ROIC)	-2.55%
Return on Capital Employed (ROCE)	-2.41%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	468,520
Profits Per Employee	-4.28M
Employee Count	27
Asset Turnover	0.07
Inventory Turnover	75.23

Taxes

Income Tax	-26.40M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-2.54%
50-Day Moving Average	1.17
200-Day Moving Average	1.30
Relative Strength Index (RSI)	48.60
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.26

Income Statement

In the last 12 months, FRA:8HX had revenue of EUR 12.65 million and -115.63 million in losses. Loss per share was -0.25.

Revenue	12.65M
Gross Profit	126,633
Operating Income	-4.11M
Pretax Income	-142.50M
Net Income	-115.63M
EBITDA	-1.25M
EBIT	-4.11M
Loss Per Share	-0.25

Full Income Statement

Balance Sheet

The company has 9.48 million in cash and 1.76 million in debt, with a net cash position of 7.73 million.

Cash & Cash Equivalents	9.48M
Total Debt	1.76M
Net Cash	7.73M
Net Cash Per Share	n/a
Equity (Book Value)	169.02M
Book Value Per Share	0.20
Working Capital	5.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.18 million and capital expenditures -149.74 million, giving a free cash flow of -143.56 million.

Operating Cash Flow	6.18M
Capital Expenditures	-149.74M
Free Cash Flow	-143.56M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	1.00%
Operating Margin	-32.47%
Pretax Margin	-1,126.49%
Profit Margin	n/a
EBITDA Margin	-9.85%
EBIT Margin	-32.47%
FCF Margin	n/a

Dividends & Yields

FRA:8HX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-204.20%
Shareholder Yield	-204.20%
Earnings Yield	-11.80%
FCF Yield	-14.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 24, 2020. It was a reverse split with a ratio of 0.3333333333.

Last Split Date	Aug 24, 2020
Split Type	Reverse
Split Ratio	0.3333333333

Scores

FRA:8HX has an Altman Z-Score of 19.49 and a Piotroski F-Score of 3.

Altman Z-Score	19.49
Piotroski F-Score	3